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  In this study, cyanidin-3-glucoside (C3G) fraction extracted from the mulberry fruit (Morus alba L.) 
was investigated for its neuroprotective effects against oxygen-glucose deprivation (OGD) and 
glutamate-induced cell death in rat primary cortical neurons. Cell membrane damage and 
mitochondrial function were assessed by LDH release and MTT reduction assays, respectively. A 
time-course study of OGD-induced cell death of primary cortical neurons at 7 days in vitro (DIV) 
indicated that neuronal death was OGD duration-dependent. It was also demonstrated that OGD for 
3.5 h resulted in approximately 50% cell death, as determined by the LDH release assay. Treatments 
with mulberry C3G fraction prevented membrane damage and preserved the mitochondrial function 
of the primary cortical neurons exposed to OGD for 3.5 h in a concentration-dependent manner. 
Glutamate-induced cell death was more pronounced in DIV-9 and DIV-11 cells than that in DIV-7 
neurons, and an application of 50μM glutamate was shown to induce approximately 40% cell death 
in DIV-9 neurons. Interestingly, treatment with mulberry C3G fraction did not provide a protective 
effect against glutamate-induced cell death in primary cortical neurons. On the other hand, treatment 
with mulberry C3G fraction maintained the mitochondrial membrane potential (MMP) in primary 
cortical neurons exposed to OGD as assessed by the intensity of rhodamine-123 fluorescence. These 
results therefore suggest that the neuroprotective effects of mulberry C3G fraction are mediated by 
the maintenance of the MMP and mitochondrial function but not by attenuating glutamate-induced 
excitotoxicity in rat primary cortical neurons.
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INTRODUCTION
  Strokes cause 9% of all deaths worldwide and are the 
third most common cause of death after ischemic heart dis-
ease and cancer. Moreover, given that 76% of people survive 
strokes in the United States and Europe, this condition is 
also the leading cause of adult disability [1]. The central 
goal of therapy in acute ischemic stroke is to preserve the 
area of oligemia in the ischemic penumbra. The area of oli-
gemia can be preserved by limiting the severity of ischemic 
injury (i.e., neuronal protection) or by reducing the duration 
of ischemia (i.e., restoring blood flow to the compromised 
area). Despite a large number of studies on neuroprotec-
tion, no successful neuroprotective agents have shown to 
be clinically effective in the treatment of ischemic brain in-
jury [2-4]. Therefore, the development of neuroprotective 
agents to prevent or treat this disorder is a current 
challenge.
  Excitotoxicity,  oxidative  stress, and an excessive in-
flammatory response are all implicated in the pathogenesis 
of ischemic and reperfusion injury [5-7]. The major ex-
citatory neurotransmitter glutamate plays important roles 
in the physiological functions of the central nervous system 
(CNS) and contributes to the pathogenesis of ischemia/hy-
poxia-induced neuronal injury [5,8]. Reactive oxygen spe-
cies (ROS) have also been demonstrated to be overproduced 
in neural tissues during ischemia-reperfusion and have 
been indicated as one of the earliest and most important 
components of tissue injury in ischemic tissues [9]. The ex-
cessive production of ROS during cerebral ischemia-re-
perfusion can cause cellular damage via the oxidation of 
vital cellular components, such as lipids, proteins and DNA 
[10]. Other important targets of ROS are mitochondria, and 
mitochondrial dysfunction during ischemia/hypoxia results 
in neural injury [9,11]. Although the precise mechanisms 354 MIH Bhuiyan, et al
Fig. 1. Double fluorescent immunocytochemistry of DIV-7 rat primary cortical neurons in serum-free Neurobasal medium supplemented 
with B27. The cells were identified as astrocytes using an anti-GFAP antibody (red; A) or as neurons using an anti-NeuN antibody (green; 
B). Astrocyte contamination was ＜1% in this serum-free culture condition.
underlying ischemia/hypoxia-induced neuronal cell death 
are not completely understood, there is a growing interest 
in establishing natural antioxidants and dietary supple-
ments as potential therapeutic agents to combat ische-
mia-induced damage to the CNS [12-14].
  Many studies have highlighted an important role for the 
neuroprotective action of dietary antioxidant components, 
including vitamins and phenolic compounds [15,16]. Antho-
cyanins are natural pigments belonging to the family of 
phenolic compounds and consist of a basic skeleton of either 
2-phenylbenzopyrilium or flavylium glycoside. Anthocya-
nins are widely distributed in the human diet and are pres-
ent in beans, vegetables and fruits. It has been reported 
that anthocyanin-rich berry extracts are protective in ische-
mia-reperfusion injury models of the heart [17], liver [18], 
brain [19], and in a traumatic spinal cord injury model [20]. 
Berry anthocyanins have also been shown to be protective 
against oxidative stress-induced PC12 cell death [19,21]. 
Furthermore, in folk medicine, mulberry (Morus alba L.) 
fruit has been used to treat and prevent diabetes, in-
flammation and fatigue. Therefore, mulberry anthocyanin 
may have protective effects against the ischemia-induced 
neuronal damage associated with excitotoxicity, oxidative 
stress, and inflammation. However, the neuroprotective ac-
tivity of anthocyanin extracted from mulberry, known to 
contain only one type of anthocyanin, namely cyanidin-3- 
glucoside (C3G) [22], has not been examined in experi-
mental models of oxygen-glucose deprivation (OGD) or in 
glutamate-induced excitotoxic cell death in primary cortical 
neurons. In this study, we, therefore, investigated the neu-
roprotective potential of C3G fraction extracted from mul-
berry fruit using a well-characterized culture of serum-free, 
highly pure rat primary cortical neurons.
METHODS
Materials
  The tissue culture dishes and plates were purchased from 
TPP (Trasadingen, Switzerland). Dulbecco’s modified Eagle 
medium (DMEM), Hank’s balanced salt solution (HBSS), 
Neurobasal medium, supplement B27, supplement B27 
without antioxidants, glutamine, penicillin/streptomycin, 
fetal bovine serum (FBS) and trypsin were all purchased 
from GIBCO BRL (Grand Island, NY). The dye rhod-
amine-123 was purchased from Molecular Probes (Eugene, 
OR), and L-glutamic acid was purchased from TOCRIS bio-
science (Ellisville, MO). All other reagents were obtained 
from Sigma-Aldrich Co. (St. Louis, MO), unless indicated 
otherwise.
Extraction of C3G fraction from mulberry fruits
  C3G fraction from mulberry fruit was prepared at Rural 
Development Administration, Suwon, Korea [23]. Briefly, 
following the addition of 0.1% citric acid-70% ethanol, fresh 
mulberry fruits were crushed manually and mixed three 
times at room temperature. The colored solution was imme-
diately collected and filtered. The solution was subsequent-
ly evaporated using a large-scale evaporation system. C3G 
concentrate was then mixed with dextrin and freeze-dried. 
The lyophilized mulberry C3G fraction was stored at −70
oC 
until use.
Drug preparation and treatment
  The stock solution of mulberry C3G fraction was pre-
pared fresh prior to every experiment at a concentration 
of 50 mg/ml in 100% dimethyl sulfoxide (DMSO). The mul-
berry C3G fraction was further diluted in Neurobasal me-
dia or in HEPES-buffered balanced salt solution (BSS) con-
taining 5.4 mM KCl, 125 mM NaCl, 20 mM HEPES, 1.8 
mM CaCl2, and 0.01 mM glycine, pH 7.35. The final concen-
tration of DMSO was ＜0.02%, which did not affect cell 
viability. The stock solutions of glutamate and MK801 were 
prepared in distilled water. The MK801 was used at a con-
centration of 1μM throughout the study. The cells were 
treated with mulberry C3G fraction throughout the entire 
experiment i.e., from 24 h prior to the OGD insult until 
24 h following OGD (Fig. 2A), unless otherwise indicated.
Primary culture of rat cortical neurons
  Primary cortical neurons were prepared from Sprague- 
Dawley rats (Koatech, Gyeonggi, Korea) at 17 embryonic 
days according to a previously established method [24,25] 
with few modifications. Briefly, cerebral cortices from fetal 
rat brains (free of meninges, olfactory bulbs, striata and 
hippocampi) were pooled, chopped in Ca
2+- and Mg
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Fig. 2. The experimental design of the OGD-model in rat primary 
cortical neurons (A). OGD-duration-dependent neuronal cell death 
(B). DIV-7 rat primary cortical neurons were transiently placed in 
an anaerobic chamber for the indicated duration (1∼4 h), and 
neuronal injury was assessed using LDH release assay 24 h 
following the simulated reperfusion. The values are given as the 
mean±S.E.M. of at least four independent experiments with 
different culture batches; *p＜0.01 compared with the sham.
HBSS and incubated with 0.025% trypsin for 10 min at 
37
oC. The enzymatic digestion was terminated by mixing 
the suspension with an equal volume of DMEM supple-
mented with 10% FBS. The cells were passed through cell 
strainers (BD Falcon, Bedford, MA) and collected by brief 
centrifugation. The dissociated cells were plated on 24-well 
plates (pre-coated with 10μg/ml poly-L-lysine) at a density 
of 3.2×10
5 cells/well in seeding medium consisting of 
Neurobasal medium supplemented with 2% B27, 0.5 mM 
glutamine, 25μM glutamate, 50 units/ml penicillin, and 50
μg/ml streptomycin. The cultures were maintained at 37
oC 
in a humidified incubator with 5% CO2/95% air (normoxia). 
One day following plating, the seeding medium was re-
moved and replaced with maintenance medium (seeding 
medium without glutamate) and refreshed twice a week. 
Neurons are the principal surviving cell type under these 
serum-free culture conditions [26]. These cultures were 
composed of more than 99% neurons, as determined by im-
munocytochemical staining with mouse anti-neuron specific 
nuclear protein (NeuN) and mouse anti-glial fibrillary acid-
ic protein (GFAP) antibodies (Fig. 1). Each of the experi-
ments was performed using Neurobasal medium (without 
phenol red) containing 2% antioxidant-free B27 supplement 
to rule out the anti-oxidant effects of the medium.
Oxygen-glucose deprivation
  To simulate ischemic injury in vitro, primary cultured 
cortical neurons were subjected to OGD according to a pre-
viously established method [24,25] with few modifications. 
Briefly, at 7 days in vitro (DIV), the cells were washed twice 
with glucose-free BSS. To initiate OGD, deoxygenated glu-
cose-free BSS (bubbled with 100% N2 for 20 min) was added 
to the cultures, and the plates were immediately trans-
ferred to an anaerobic chamber (Thermo Electron, Wal-
tham, MA), which had been previously rinsed with an anae-
robic gas mixture (5% CO2, 10% H2 and 85% N2). The cells 
were maintained in the chamber at 37
oC for 3.5 h to induce 
the ischemic insult. The oxygen concentration inside the 
anaerobic chamber was monitored occasionally with an 
anaerobic indicator strip (Oxoid Ltd., Hampshire, England). 
Following 3.5 h in anaerobic and glucose-free conditions, 
the OGD was terminated by changing the deoxygenated 
BSS to pre-warmed Neurobasal media containing anti-
oxidant-free B27 supplements and returning the cells to a 
normal culture incubator. This reoxygenation incubation 
period is similar to the reperfusion period in in vivo ische-
mic injuries. Sham group neurons were washed twice with 
glucose-free BSS, incubated with BSS containing 25 mM 
glucose for 3.5 h in the normal culture incubator, and ex-
posed to simulated reperfusion for 24 h.
Glutamate-induced neurotoxicity
  At DIV-9, primary cortical neurons were washed with 
BSS containing 15 mM glucose. The cells were subsequent-
ly incubated with 50μM glutamate diluted in BSS for 10 
min in the presence or absence of mulberry C3G fraction 
in a normal culture incubator. Following glutamate ex-
posure, the neurons were washed twice with BSS and re-
freshed with pre-warmed Neurobasal media with or with-
out mulberry C3G fraction for 24 h. 
Assessment of neuronal injury
  Neuronal injury was assessed using the lactate dehydro-
genase (LDH) release and mitochondrial MTT (3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduc-
tion assays 24 h after OGD or glutamate exposure. Damage 
to the cell membrane of primary cortical neurons was quan-
titatively evaluated by determining the levels of LDH re-
leased from injured cells into the bathing medium 24 h fol-
lowing the end of OGD or glutamate exposure using the 
Cytotoxicity Detection Kit Plus (Roche, Mannheim, Ger-
many) according to the manufacturer’s instructions. Briefly, 
100μl of sample medium was transferred from the culture 
wells to 96-well plates, mixed with 100μl of the reaction 
mixture provided by the kit, and incubated for 15 min at 
room temperature in the dark. After adding 50μl of stop 
solution, the absorbance (Abs) of the sample at 490 nm was 
determined using a multilabel counter system (Perkin 
Elmer, Boston, MA). The medium of completely lysed cells 
was defined as 100% LDH release. The absorbance values 
of normal background (normal media plus reaction mixer) 
were subtracted from values from the treatment and lysed 
groups. LDH (%) release was determined by the following 
ratio: Abs490 in the sample medium/Abs490 in the lysed cell 
medium. Using an MTT reduction assay, neuronal cell via-
bility was estimated. This determination is based on the 
cleavage of yellow MTT salt into purple formazan by the 
mitochondrial dehydrogenase enzyme in viable cells. Brief-
ly, following 24 h simulated reperfusion, fresh medium con-
taining the MTT salt at a final concentration of 0.25 mg/ml 
was added to cultures and incubated for 1 h in a normal 
culture incubator. Following incubation, the medium was 
aspirated and DMSO was added to dissolve the insoluble 
purple formazan product into a colored solution, which was 
analyzed at a wavelength of 570 nm using a multilabel 
counter system (Perkin Elmer, Boston, MA). The absorb-
ance of the formazan formed in the un-treated cells 356 MIH Bhuiyan, et al
Fig. 3. The neuroprotective effect of mulberry C3G fraction against OGD-induced neuronal cell death. DIV-7 rat primary cortical neurons 
were exposed to OGD for 3.5 h with or without mulberry C3G fraction. Cell survival and death were measured 24 h following simulated 
reperfusion using the MTT reduction (A) and LDH release assays (B), respectively. The values are given as the mean±S.E.M. of at least 
six independent experiments. 
#p＜0.01 compared with the sham. *p＜0.05 and **p＜0.01 compared with OGD without mulberry C3G fraction.
(controls) was defined as 100% viability.
Measurement of mitochondrial membrane potential 
(MMP)
  The change in the MMP was measured in live primary 
cortical neurons using the fluorescent dye rhodamine-123. 
Primary cortical neurons grown on 24-well plates were 
loaded with 5μM rhodamine-123 in BSS. The cells were 
incubated for 10 min at 37
oC in a normal culture incubator 
and washed three times with BSS. The fluorescence signal 
of rhodamine-123 was read using a multilabel counter sys-
tem (Perkin Elmer, Boston, MA). The background fluo-
rescence signal of rhodamine-123 was also determined from 
wells without cells and was subtracted from the rhod-
amine-123 signals obtained from all sample wells. The 
MMP was calculated as the ratio of the fluorescent in-
tensity of the sample cells to the intensity of the control 
(non-treated) cells. Fluorescent images of cells were cap-
tured at 20× using an Olympus IX70 inverted fluorescence 
microscope fitted with a digital color camera (Aomori 
Olympus, Tokyo, Japan).
Double immunofluorescence staining
  To analyze the immunofluorescence data, primary cort-
ical neurons grown on 12-mm glass coverslips (Deckglaser, 
Carolina Biologicals, Burlington, NC) were washed with 
Dulbecco’s phosphate buffered saline (DPBS, pH 7.4), fixed 
with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4) for 10 min, permeabilized with 0.1% Triton X-100 for 
10 min, and washed with DPBS (5 min×3). After blocking 
with 10% normal goat serum for 1 h at room temperature, 
the cells were incubated with the primary antibody over-
night at 4ºC. The primary and secondary antibodies were 
diluted with 3% normal goat serum, and care was taken 
to avoid their exposure to light during the experiment. 
First, the cells were incubated with mouse anti-GFAP (1：
500) (Chemicon, Temecula, CA) primary antibody over-
night. The next day, the cells were washed and incubated 
with anti-mouse secondary antibody conjugated with Cy3 
(1：500; Jackson ImmunoResearch, West Grove, PA) for 1 
h. After washing, the cells were incubated with mouse an-
ti-NeuN (1：200) antibody conjugated with Alexa-Fluor488 
(Chemicon, Temecula, CA) for 2 h at room temperature. 
Following the final DPBS (5 min×3) wash, the glass cover-
slips were mounted onto saline-coated slides with the fluo-
rescent mounting media ProLong
TM Gold (Invitrogen, 
Grand Island, NY). The cells were examined under a fluo-
rescence microscope (AxioImager, Carl Zeiss, Jena, Ger-
many).
Statistical analyses
  Each group consisted of 3∼4 culture wells per experi-
ment and each set of experiments was performed at least 
three times with different culture batches. The data are ex-
pressed as the mean±the standard error of the mean 
(S.E.M). All statistical analyses were performed using 
SPSS 13.0 software (SPSS Inc., Chicago, IL). Statistical sig-
nificance was assessed using the one-way analysis of var-
iance for multiple group comparisons followed by Tukey’s 
post hoc test. A p-value of less than 0.05 was considered 
to be statistically significant.
RESULTS
Oxygen-glucose deprivation-induced neuronal cell death
  In this study, a serum-free, highly pure rat primary cort-
ical neuron culture (Fig. 1) was used to examine the neuro-
protective activity of C3G fraction extracted from mulberry. 
To mimic cerebral ischemia in vitro, we used an OGD model 
of primary neurons cultured on 24-well plates. Preliminary 
experiments indicated that DIV-10 neurons appeared to be 
more resistant to OGD-reperfusion injury than DIV-7 neu-
rons (data not shown). DIV-7 cells were, therefore, used for 
a time-course study of OGD-induced cell death. The re-
sultant neuronal injury was quantified using the LDH re-
lease assay following 24 h of simulated reperfusion. It was 
observed that neuronal cell death depended on the duration 
of the OGD (Fig. 2B). The observed cell death in the sham 
group was 8.9±1.1%, whereas exposure to OGD for 1, 2, 3, 
and 4 h increased cell death to 16.7±3.5%, 22.7±4.3%, 
37±5.2%, and 61.3±2.1%, respectively. Therefore, DIV-7 
neurons and 3.5 h of OGD were chosen to simulate ischemia 
in vitro in the subsequent experiments.Neuroprotection of Mulberry C3G Fraction Against OGD 357
Fig. 4. The effects of different glutamate concentrations and culture 
durations on glutamate-induced neurotoxicity. Sister cultures of rat 
primary cortical neurons cultured for different periods of time were 
incubated with different concentrations of glutamate for 10 min. 
The resultant neuronal injury was assessed using the LDH release 
assay 24 h following the glutamate exposure. The values are given 
as the mean of at least four independent experiments with different 
culture batches.
Fig. 5. The effects of mulberry C3G fraction on glutamate-induced neurotoxicity. DIV-9 cells were exposed to 50μM of glutamate with 
or without mulberry C3G fraction. Cell survival and death were measured 24 h following glutamate exposure using the MTT reduction 
(A) and LDH release assays (B), respectively. The values are given as the mean±S.E.M. of at least four independent experiments with 
different culture batches. 
#p＜0.01 compared with the sham. *p＜0.05 compared with glutamate without mulberry C3G fraction treatment.
Neuroprotective effect of mulberry C3G fraction again-
st in vitro ischemia-induced cell death
  We examined whether C3G fraction extracted from mul-
berry was able to protect primary cortical neurons against 
OGD-induced neuronal cell death. In the first series of ex-
periments, the effect of C3G fraction alone on cell viability 
was determined using the MTT reduction assay. The treat-
ment of primary cortical neurons with 1, 5, 10, 20, and 50 
μg/ml mulberry C3G fraction did not affect cell viability 
(data not shown). The exposure of primary cortical neurons 
to OGD for 3.5 h and reperfusion for 24 h resulted in a 
significant decrease in cell viability (37.6±5.3% in the OGD 
group compared to 95.1±1.6% in the sham group), as de-
termined by the MTT reduction assay (Fig. 3A). On the oth-
er hand, treatment of neurons with mulberry C3G fraction 
at concentrations of 5 and 10μg/ml provided neuro-
protection, increasing cell viability up to 61.5±8.0% and 
61.4±7.3%, respectively. Moreover, to examine ischemia-in-
duced membrane damage, we assessed the protective effect 
of mulberry C3G fraction on OGD-induced cellular damage 
using the LDH release assay. Treatment with mulberry 
C3G fraction at concentrations of 5 and 10μg/ml decreased 
LDH release to 30.8±3.1% and 29.9±2.6%, respectively, 
compared to 47.2±3.4% in the OGD-reperfusion group (Fig. 
3B), thereby indicating that mulberry C3G fraction sig-
nificantly attenuates neuronal membrane damage.
Glutamate induces excitotoxic cell death in primary 
cortical neurons
  To examine the toxic effects of glutamate, primary cort-
ical neurons cultured in vitro for different periods of time 
(DIV-7, -9 and -11) were exposed to various concentrations 
(25∼500μM) of glutamate for 10 min. Twenty four hours 
following glutamate exposure, cell death was assessed us-
ing the LDH release assay. As shown in Fig. 4, gluta-
mate-induced cell death was dependent on the period of 
time that the primary cortical neurons had been in culture. 
The LDH release assay indicated that glutamate-induced 
cell death in both DIV-9 and DIV-11 cells was greater than 
that observed in DIV-7 neurons. At a glutamate concen-
tration of 50μM, cell death was induced at the rates of 
23.9±2.2%, 41.3±5.0%, and 49.0±5.7% in DIV-7, -9 and -11 
cultures, respectively. Because neuronal purity is compro-
mised over 10 days in vitro, we chose DIV-9 cells to perform 
the subsequent glutamate toxicity experiments. At this 
stage, the culture is highly pure, and the cells are mature 
enough in terms of receptor expression and glutamate sen-
sitivity [26,27]. The toxic effects of glutamate on DIV-9 and 
DIV-11 neurons did not linearly increase at concentrations 
higher than 50μM, and moderate cell deaths were ob-
served at this concentration. Therefore, DIV-9 cultures and 
a glutamate concentration of 50μM were chosen as ex-
perimental conditions for the following studies of the neuro-
protective effects of mulberry C3G fraction against ex-
citotoxic cell death.
Effect of mulberry C3G fraction on glutamate-induced 
primary cortical neuronal cell death
  Having established that 50μM of glutamate induces neu-
rotoxicity in cortical neurons, we examined whether mul-
berry anthocyanin has a protective effect against gluta-
mate-induced toxicity in DIV-9 neurons. Primary cultured 
cortical neurons treated with or without various concen-358 MIH Bhuiyan, et al
Fig. 6. The effects of mulberry C3G fraction on MMP maintenance in primary cortical neurons subjected to OGD. DIV-7 cells were exposed
to OGD for 3.5 h with or without mulberry C3G fraction treatment. Following 24 h of simulated reperfusion, the MMP was measured 
using the fluorescent dye rhodamine-123. Representative fluorescent images of sham-treated cells (A), cells subjected to OGD only (B) 
and cells subjected to OGD with 5μg/ml of mulberry C3G fraction (C). The scale bar is 100 mm. The bar graph (D) summarizes the 
fluorescence measurements from different groups. The values are given as the mean±S.E.M. of at least three independent experiments 
with different culture batches. 
#p＜0.01 compared with the sham. *p＜0.05 compared with OGD without mulberry C3G fraction treatment.
trations of mulberry C3G fraction (1∼10μg/ml) and the 
non-competitive NMDA receptor antagonist MK801 (1μM) 
were exposed to 50μM of glutamate for 10 min. Following 
24 h of glutamate exposure, neuronal injury was measured 
using the MTT reduction and LDH release assays. As illus-
trated in Fig. 5A, the treatment of primary cortical neurons 
with MK801 increased neuronal cell viability (90.3±3.1% vs. 
53.4±1.78%) compared to glutamate-treated neurons in the 
absence of MK801. Treatment with MK801 also decreased 
glutamate-induced neuronal cell death, as determined by 
the observed reduction of LDH release (11.6±1.2% vs. 38.8± 
4.6%) (Fig. 5B) compared to glutamate-treated neurons in 
the absence of MK801. Moreover, cell viability was 58.2± 
1.3% and 57.0±1.6% in the mulberry C3G fraction-treated 
group at 5 and 10μg/ml, respectively. The LDH release as-
say indicated that cell death was 36.7±4.6% and 38.0±5.4% 
in the mulberry C3G fraction-treated group at 5 and 10 
μg/ml, respectively. Neither cell viability nor cell death in 
the C3G fraction- plus glutamate-treated groups were sig-
nificantly different from the respective groups treated with 
glutamate only. These results suggest that C3G fraction ex-
tracted from mulberry is not effective against glutamate-in-
duced excitotoxic cell death in rat primary cortical neurons.
Effect of mulberry C3G fraction on MMP
  To examine the mechanism underlying the neuropro-
tective effects of C3G fraction extracted from mulberry, we 
investigated the effects of this extract on the MMP of pri-
mary cortical neurons exposed to OGD-reperfusion. The flu-
orescent dye rhodamine-123 was used to evaluate changes 
in MMP in primary cortical neurons, and the fluorescent 
intensity was expressed as the ratios of the fluorescence 
of treated neurons over that of control (un-treated) neurons. 
Relative to sham group (Fig. 6A), the fluorescence intensity 
in the OGD group was decreased (Fig. 6B). The treatment 
of neurons with 5μg/ml of mulberry C3G fraction preserved 
the signal intensity considerably, indicating a substantial 
ability of mulberry C3G fraction to maintain a polarized 
mitochondrial membrane potential (Fig. 6C) in primary 
cortical neurons subjected to OGD. Quantitative analyses 
indicated that the OGD insult resulted in a drastic decrease 
in the MMP signal intensity, which was 26.4±7.8% in the 
OGD-subjected group and 94.7±3.7% in the sham group. In 
contrast, treatment with mulberry C3G fraction resulted 
in a significant maintenance of the MMP signal intensity 
in primary cortical neurons exposed to OGD-reperfusion. 
Signal intensity values were 59.6±8.2% and 59.7±7.8% at 
C3G concentrations of 5 and 10μg/ml, respectively (Fig. 
6D).
DISCUSSION
  The cellular and molecular cascades underlying ischemic 
injury are multifaceted and complex [7]. Excitotoxicity, oxi-
dative stress, and an excessive inflammatory response have 
been implicated in the progressive neuronal injury and cell 
death observed post-ischemia [9,11]. ROS overproduction 
has been identified as one of the earliest and most im-Neuroprotection of Mulberry C3G Fraction Against OGD 359
portant mediators of tissue injury during the ischemia-re-
perfusion insult. For this reason, and because of their pos-
itive roles against ischemia-reperfusion injury, much atten-
tion has recently been focused on natural antioxidants. 
Anthocyanin-rich berry extracts and their major component 
C3G are known to possess antioxidant and anti-inflamma-
tory activity in various disease models [28-31]. In this 
study, we evaluated the neuroprotective activity of C3G 
fraction extracted from mulberry in models of OGD-re-
perfusion and glutamate-induced cell death in rat primary 
cortical neurons. The results of this study indicate that 
mulberry C3G fraction is neuroprotective against OGD-in-
duced primary cortical neuronal death. Furthermore, this 
protection was conferred, at least in part, via the inhibition 
of membrane damage and the preservation of the MMP and 
mitochondrial function.
  The OGD model is considered to be the closest simulation 
of cerebral ischemia for studying ischemia in vitro and has 
been used in numerous ischemia-related studies [32-34]. In 
this study, highly pure cultures of primary cortical neurons 
were prepared from embryonic day 17 fetal rat brains. The 
neurons were plated onto pre-coated culture surfaces with 
Neurobasal media (favorable to neurons) without serum 
supplements. Suitable conditions were subsequently estab-
lished to induce progressive neuronal death following in vi-
tro ischemia. It was found that some neurons exhibited a 
swollen morphology and branched off immediately follow-
ing OGD. Widespread neuronal degeneration occurred over 
the reperfusion period, despite the resupply of normal oxy-
gen and glucose levels. In this study, we observed that the 
treatment of primary cortical neurons with mulberry C3G 
fraction prevented OGD/reperfusion-induced neuronal de-
generation. It has been reported that the presence of glial 
cells in the culture and/or serum supplementation in the 
media regulates and promote cell survival in primary neu-
ron cultures [35-38]. Because our culture was highly pure 
neuronal and was serum-free, it can be inferred that mul-
berry C3G fraction afforded the neuroprotection observed 
in primary cortical neurons against the damage induced by 
the OGD-reperfusion.
  The events mediating cell death in the context of OGD 
include ATP depletion, excitotoxicity, and oxidative stress, 
all of which are associated with mitochondrial function [11]. 
Both oxidative stress and ATP depletion are reported to be 
involved in mitochondrial dysfunction, which is marked by 
the collapse of the mitochondrial trans-membrane poten-
tial. Furthermore, the loss of the MMP alters mitochondrial 
membrane permeability. We examined MMP changes in 
primary cortical neurons that were subjected to the OGD- 
reperfusion using rhodamine-123, a cell permeable cationic 
fluorescent dye that can be used to directly measure the 
MMP. Our results indicate that mulberry C3G fraction pre-
vents OGD-reperfusion-induced MMP loss in primary cort-
ical neurons. These results suggest that the protection of 
mitochondria from OGD-induced stress is a possible mecha-
nism by which mulberry C3G fraction blocks cell death. In 
this regard, Kang et al. [19] reported that C3G, the major 
anthocyanin component in mulberry fruit, exhibited a sig-
nificant neuroprotective effect against OGD-induced PC12 
cell death. In support of our findings, this group also found 
that crude mulberry extract and C3G were neuroprotective 
against in vivo cerebral ischemia in mouse and H2O2-induc-
ed oxidative stress in PC12 cells. Surprisingly, this group 
did not report a protective effect of crude extract of mul-
berry against OGD-induced PC12 cell death, even at a con-
centration of 10μg/ml. These conflicting findings may be 
due to the different cell types, extraction solvents, protocols, 
and/or drug treatment schedules used. The prior re-
searchers used immortal PC12 cells, whereas we used se-
rum-free primary cortical neurons, which are widely used 
to mimic cerebral ischemia in vitro. Another crucial differ-
ence between these two studies was the use of solvents to 
extract anthocyanin from the mulberry fruit. In their study, 
methanol was used for anthocyanin extraction. Although 
methanol is more efficient to extraction of anthocyanins 
[23], methanolic extract is not considered edible. However, 
in our study, citric acid-ethanol was used to extract C3G 
from mulberry fruit. This substance is edible and has the 
potential to be used as a supplement following further stud-
ies in animal models and/or clinical trials. Moreover, we 
observed a neuroprotective effect of mulberry C3G fraction 
at a concentration of 5μg/ml in more severe OGD settings 
(3.5 h vs. 2 h, and ≈37% vs. ≈55% of cell viability), which 
may be due to the differences in drug-treatment schedules. 
Kang et al. treated PC12 cells with mulberry crude extract 
and C3G during only 2 h of OGD, whereas we treated pri-
mary neurons with C3G fraction beginning 24 h prior to 
the OGD insult until 24 h following the OGD. Therefore, 
it appears that pre- and post-treatments of neurons with 
mulberry C3G fraction may contribute to the neuropro-
tective effect of this extract at a relatively lower concen-
tration. However, the additive neuroprotective effect of oth-
er component(s) present in crude C3G fraction cannot be 
excluded, given that the mulberry C3G fraction used in our 
study was not 100% pure.
  Glutamate-induced excitotoxicity can also contribute to 
neuronal damage and degeneration following in vivo cere-
bral ischemia [39,40] and in vitro hypoxia/ischemia models, 
including OGD [8,34,41]. To determine the mechanism of 
the observed neuroprotective effect induced by mulberry 
C3G fraction against OGD, we, therefore, tested the effect 
of mulberry C3G fraction on glutamate-induced primary 
neuronal cell death. It was found that mulberry C3G frac-
tion did not inhibit primary cortical neuronal death follow-
ing glutamate treatment. To our knowledge, there have 
been no reports demonstrating the effects of anthocyanins, 
including C3G, against glutamate-induced excitotoxicity in 
vitro. However, one in vivo study reported that bilberry ex-
tracts inhibited NMDA-induced retinal damage in mice 
[30]. Because bilberry extract consists of approximately 15 
different anthocyanins [30,42], it is possible that anthocya-
nin components other than C3G may exhibit anti-ex-
citotoxic activity. However, further studies are required to 
verify the effects of anthocyanins, including the actions of 
C3G against excitotoxic insults.
  Many studies have demonstrated the beneficial effects of 
anthocyanins, including C3G, against numerous degener-
ative diseases [17-21,28-31]. To our knowledge, however, no 
reports have demonstrated adverse effects of C3G. However, 
one study by Ziberna et al. (2010) reported cardiotoxic ef-
fects of relatively high concentrations of anthocyanins ex-
tracted from bilberry fruit [43]. It was shown that at con-
centrations of 0.1∼5μg/ml, anthocyanins extracted from 
bilberries conferred cardioprotective effects against ische-
mia-reperfusion injury in isolated rat hearts. However, con-
centrations of 20∼50μg/ml significantly increased LDH re-
lease in ischemic hearts compared to control, untreated is-
chemic hearts. In our study, concentrations of 5∼10μg/ml 
mulberry C3G fraction exhibited neuroprotective activity 
against OGD-induced death in primary neurons. Because, 360 MIH Bhuiyan, et al
we did not examine the neuroprotective activity of mulberry 
C3G fraction at concentrations greater than 10μg/ml, it is 
possible that higher concentrations may result in dimin-
ished neuroprotection or even facilitate toxicity in the con-
text of ischemia-reperfusion. In fact, our preliminary cyto-
toxicity test indicated that the incubation of rat primary 
cultured cortical neurons with much higher concentrations 
(100μg/ml) of mulberry C3G fraction results in neuronal 
death, even under physiological conditions (data not shown). 
Therefore, further studies are required to determine wheth-
er there are any adverse effects linked to higher concen-
trations of mulberry C3G fraction in the context of ische-
mia-reperfusion.
  In conclusion, our study demonstrates the protective ef-
fects of C3G fraction extracted from mulberry fruits against 
OGD-reperfusion-induced neuronal injury. Our results also 
indicate that these neuroprotective effects are partly medi-
ated by the maintenance of mitochondrial function and 
MMP but not by the inhibition of glutamate-induced ex-
citotoxicity in rat primary cortical neurons. Although fur-
ther studies of the effects of anthocyanins are required in 
different models of hypoxia/ischemia and other neurodegen-
erative diseases, the present study provides important in-
formation regarding the neuroprotective activities of mul-
berry C3G fraction against ischemia-induced neuronal cell 
death.
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